Abstract:Mitochondria play an important and multifaceted role in cellular function, catering to the cell's energy and biosynthetic requirements. They modulate apoptosis while responding to diverse extracellular and intracellular stresses including reactive oxygen species (ROS), nutrient and oxygen scarcity, endoplasmic reticulum stress, and signaling via surface death receptors. Integral components of mitochondria, such as mitochondrial DNA (mtDNA), mitochondrial RNA (mtRNA), Adenosine triphosphate (ATP), cardiolipin, and formyl peptides serve as major damage-associated molecular patterns (DAMPs). These molecules activate multiple innate immune pathways both in the cytosol [such as Retionoic Acid-Inducible Gene-1 (RIG-1) and Cyclic GMP-AMP Synthase (cGAS)] and on the cell surface [including Toll-like receptors (TLRs)]. This activation cascade leads to the release of various cytokines, chemokines, interferons, and other inflammatory molecules and oxidative species. The innate immune pathways further induce chronic inflammation in the tumor microenvironment which either promotes survival and proliferation or promotes epithelial to mesenchymal transition (EMT), metastasis and therapeutic resistance in the cancer cell's. Chronic activation of innate inflammatory pathways in tumors also drives immunosuppressive checkpoint expression in the cancer cells and boosts the influx of immune-suppressive populations like Myeloid-Derived Suppressor Cells (MDSCs) and Regulatory T cells (Tregs) in cancer. Thus, sensing of cellular stress by the mitochondria may lead to enhanced tumor growth. In addition to that, the tumor microenvironment also becomes a source of immunosuppressive cytokines. These cytokines exert a debilitating effect on the functioning of immune effector cells, and thus foster immune tolerance and facilitate immune evasion. Here we describe how alteration of the mitochondrial homeostasis and cellular stress drives innate inflammatory pathways in the tumor microenvironment.

Role of Mitochondrial Stress Response in Cancer Progression

Research Progress on Mitochondria Regulating Tumor Immunity.

The Role of Mitochondrial Dynamics and Mitophagy in Carcinogenesis, Metastasis and Therapy.

Mitochondria and Cancer

The role of mitochondria in tumor metastasis and advances in mitochondria-targeted cancer therapy

Mitochondrial Redox Signaling And Tumor Progression

Mitochondria driven innate immune signaling and inflammation in cancer growth, immune evasion, and therapeutic resistance

Role of mitochondrial alterations in human cancer progression and cancer immunity

Mitochondrial oxidative stress in the tumor microenvironment and cancer immunoescape: foe or friend?

Mitochondrial adaptation in cancer drug resistance: prevalence, mechanisms, and management

Modulation of Mitochondrial Metabolic Reprogramming and Oxidative Stress to Overcome Chemoresistance in Cancer

Mitochondria: The metabolic switch of cellular oncogenic transformation

Mitochondria act as a key regulatory factor in cancer progression: current concepts on mutations, mitochondrial dynamics, and therapeutic approach

An Overview: The Diversified Role of Mitochondria in Cancer Metabolism

The mitochondrial stress signaling tunes immunity from a view of systemic tumor microenvironment and ecosystem

Mitochondria in cancer stem cells: Achilles heel or hard armor

Mitophagy at the crossroads of cancer development: Exploring the role of mitophagy in tumor progression and therapy resistance

Mitochondria Targeting as an Effective Strategy for Cancer Therapy

The Role of Mitochondrial Dynamics in Human Cancers.

Mitochondrial Plasticity and Glucose Metabolic Alterations in Human Cancer under Oxidative Stress—From Viewpoints of Chronic Inflammation and Neutrophil Extracellular Traps (NETs)

Essential Role of Mitochondria in Tumorigenesis